Literature DB >> 25029975

Longitudinal changes in health-related quality of life for chronic diseases: an example in hemophilia A.

Jiat-Ling Poon1, Jason N Doctor, Michael B Nichol.   

Abstract

BACKGROUND: Patients with well-managed rare chronic diseases such as hemophilia maintain a stable health state and health-related quality of life (HrQoL) that may be affected by acute events. Longitudinal HrQoL assessments analyzed using multivariate multilevel (MVML) modelling can determine the impact of such events on individuals (within-person effect) and identify factors influencing within-population differences (between-person effect).
OBJECTIVES: To demonstrate the application of MVML modelling in a longitudinal study of HrQoL in hemophilia A. METHODS/DESIGN/PARTICIPANTS: Using data on 136 adults and 125 children from a two-year observational cohort study of burden of illness in US hemophilia A patients, MVML modelling determined the effect of time-invariant (sociodemographic and clinical characteristics) and time-varying factors (bleeding frequency, emergency room visits, and missed work/school days) on within-person and between-person HrQoL changes. HrQoL was assessed using the SF-12 health survey (adults) and PedsQL inventory (children) at baseline, then every 6 months.
RESULTS: In children, within-person (p < 0.0001) and between-person (p < 0.0001) psychosocial functioning was reduced by each additional bleed and missed day (within-person: p = 0.0089; between-person: p = 0.0060). Within-person physical functioning was reduced by each additional bleed (p < 0.0001), emergency room (ER) visit (p = 0.0284), and missed day (p = 0.0473). Between-persons, additional missed days (p < 0.0001) significantly decreased physical functioning. In adults, each additional missed day reduced SF-12 Health Survey mental (p = 0.0025) and physical (p = 0.0093) component summary scores. Each additional bleed also decreased physical component summary (PCS) significantly (p = 0.0093).
CONCLUSIONS: This study demonstrated the applicability of MVML modelling in identifying time-invariant and time-varying factors influencing HrQoL in a rare chronic disease population. Small but significant within-person and between-person changes in HrQoL with each additional acute event experienced were identified, which if frequent, could have a large cumulative impact. The results suggest that MVML modelling may be applied to future studies of longitudinal change in HrQoL in other rare chronic disease populations.

Entities:  

Mesh:

Year:  2014        PMID: 25029975      PMCID: PMC4124124          DOI: 10.1007/s11606-014-2893-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  13 in total

1.  Haemophilic; arthropathy: assessment of quality of life after total knee arthroplasty.

Authors:  M Schick; G Stucki; M Rodriguez; E O Meili; E Huber; B A Michel; P Brühlmann
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

2.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

3.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

4.  Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders.

Authors:  S Solovieva
Journal:  Haemophilia       Date:  2001-01       Impact factor: 4.287

5.  Haemophilia utilization group study - Part Va (HUGS Va): design, methods and baseline data.

Authors:  Z-Y Zhou; J Wu; J Baker; R Curtis; A Forsberg; H Huszti; M Koerper; M Lou; R Miller; K Parish; B Riske; A Shapiro; M Ullman; K Johnson
Journal:  Haemophilia       Date:  2011-06-20       Impact factor: 4.287

6.  Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States.

Authors:  N Duncan; A Shapiro; X Ye; J Epstein; M P Luo
Journal:  Haemophilia       Date:  2012-05-01       Impact factor: 4.287

7.  Health-related quality of life and productivity impact in haemophilia patients with inhibitors.

Authors:  T M Brown; W C Lee; A V Joshi; C L Pashos
Journal:  Haemophilia       Date:  2009-04-09       Impact factor: 4.287

8.  Acute and chronic pain in hemophilia.

Authors:  M Choinière; R Melzack
Journal:  Pain       Date:  1987-12       Impact factor: 6.961

9.  Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group.

Authors:  Alessandro Gringeri; Lorenzo G Mantovani; Luciana Scalone; Pier Mannuccio Mannucci
Journal:  Blood       Date:  2003-06-19       Impact factor: 22.113

10.  Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 Generic Core Scales.

Authors:  James W Varni; Christine A Limbers; Tasha M Burwinkle
Journal:  Health Qual Life Outcomes       Date:  2007-07-16       Impact factor: 3.186

View more
  5 in total

Review 1.  Valuing the "Burden" and Impact of Rare Diseases: A Scoping Review.

Authors:  Julien Delaye; Pasquale Cacciatore; Anna Kole
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

2.  Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).

Authors:  Johnny Mahlangu; Johannes Oldenburg; Michael U Callaghan; Midori Shima; Maria Elisa Mancuso; Peter Trask; Michael Recht; Claudia Garcia; Renchi Yang; Michaela Lehle; Harrison Macharia; Elina Asikanius; Gallia G Levy; Rebecca Kruse-Jarres; Sylvia von Mackensen
Journal:  Haemophilia       Date:  2019-04-24       Impact factor: 4.287

3.  Illness perceptions and their relation to physical activity in children and adolescents with hemophilia.

Authors:  Sarah Bérubé; Claudine Amesse; Serge Sultan
Journal:  Health Psychol Behav Med       Date:  2020-10-04

Review 4.  Clinical Evidence and Safety Profile of Emicizumab for the Management of Children with Hemophilia A.

Authors:  Sandra Le Quellec
Journal:  Drug Des Devel Ther       Date:  2020-02-03       Impact factor: 4.162

5.  Health-related quality of life of patients with haemophilia: a cross-sectional survey in the Northeast of China.

Authors:  Jinyu Niu; Liangwen Ning; Qiao Zhang; Ze Liu; Yi Ma; Xiaoxue Xu; Qunhong Wu; Yanhua Hao; Yu Cui; Chaojie Liu
Journal:  BMJ Open       Date:  2022-02-01       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.